Cambridge Cancer Genomics
CCG.ai empowers clinicians to make personalised treatment strategies…
DeadSummer 2017Biotech
About Cambridge Cancer Genomics
CCG.ai empowers clinicians to make personalised treatment strategies…
Risk Analysis
Category Risk
13%death rate
Biotech: 18 of 140 startups failed
LOWTeam Size
25people
Median for failed in Biotech: 6
Median for active in Biotech: 5
External Resources
Read full post-mortem on startups.rip ↗(opens in new tab)Website ↗(opens in new tab)YC Profile ↗(opens in new tab)Report data issue
Post-mortem content hosted on startups.rip — we provide the analytics layer.
Similar Companies
☠
Reverie Labs
Engineering next-generation, brain-penetrant cancer therapies.
Biotech13%
✓
Triomics
Generative AI for Oncology EHRs
Healthcare19%
✓
Blank Bio
RNA-based AI for better drugs and smarter clinical trials.
Biotech13%
✓
Notable Labs
Personalized drug discovery for blood cancer.
Biotech13%
✓
Oncobox
Finding the right cancer drug for each patient.
Biotech13%